✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
Nootropic Dipeptide
Also known as GVS-111 / N-phenylacetyl-L-prolylglycine ethyl ester
Noopept is a synthetic proline-containing dipeptide studied in research for nootropic and neuroprotective activity.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Noopept is a synthetic proline-containing dipeptide studied in research for nootropic and neuroprotective activity.
Experimental models examine its influence on neurotrophic signaling and cognitive-performance endpoints under controlled laboratory conditions.
Third-party tested for purity, ID, quantity.
Noopept (GVS-111) is a dipeptide analogue developed from the pyrrolidone nootropic class. Research has examined its neuroprotective behavior, including effects on neurotrophic factor expression and resistance to oxidative and excitotoxic stress in cellular and animal models.
Studies have evaluated cognitive-performance endpoints and downstream signaling such as HIF-1 activation under structured experimental conditions.
Noopept was synthesized during research into peptide analogues of racetam nootropics, intended to reproduce procognitive activity at lower doses.
Subsequent preclinical work characterized its neuroprotective and anti-inflammatory profile across multiple models.
Research into noopept focuses on neuroprotection and cognitive-pathway models. Frameworks evaluate neurotrophic signaling, oxidative-stress resistance, and inflammatory modulation under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of noopept. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
Noopept; a nootropic dipeptide, modulates persistent inflammation by effecting spinal microglia dependent Brain Derived Neurotropic Factor (BDNF) and pro-BDNF expression throughout apoptotic process
PubMedRelated
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$70.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$50.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$60.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$90.00
